site
-
Biologics
BioRestorative Therapies Announces Clinical Trial Contract with Second Site for the Company’s Phase 2 Clinical Trial to Treat Chronic Lumbar Disc Disease (cLDD)
MELVILLE, NY., June 22, 2022 (GLOBE NEWSWIRE) — BioRestorative Therapies, Inc. (the “Company” or “BioRestorative”) (NASDAQ: BRTX), a clinical stage company focused…
Read More » -
Biologics
InVivo Therapeutics Announces INSPIRE’S 29th Clinical Site: Rhode Island Hospital
January 10, 2017 CAMBRIDGE, Mass.–(BUSINESS WIRE)–InVivo Therapeutics Holdings Corp. (NVIV) today announced that Rhode Island Hospital in Providence, RI has been…
Read More » -
Extremities
EOS imaging Announces the Opening of the First EOS® Site in South Korea
November 28, 2016 PARIS–(BUSINESS WIRE)–EOS imaging (Paris:EOSI) (Euronext, FR0011191766 – EOSI), the pioneer in 2D/3D orthopedic medical imaging, announced today…
Read More » -
Biologics
InVivo Therapeutics Announces Ben Taub Hospital/Baylor College of Medicine as New Site for INSPIRE Study
July 18, 2016 CAMBRIDGE, Mass.–(BUSINESS WIRE)–InVivo Therapeutics Holdings Corp. (NVIV) today announced that the Ben Taub Hospital in Houston, TX…
Read More » -
Biologics
Pioneering global regenerative medical technology company, Tissue Regenix Group plc, officially opens new Leeds site
LEEDS, England–(BUSINESSWIRE)– Tissue Regenix Group plc is pleased to announce the official opening of its new Leeds-based manufacturing centre. This…
Read More » -
Spine
Nuvasive Announces Location For New State-Of-The-Art Manufacturing Facility
SAN DIEGO, CA – December 10, 2015 – NuVasive, Inc. (NASDAQ: NUVA), a leading medical device company focused on transforming spine surgery…
Read More »